Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival

Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival

Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers worldwide, primarily due to its robust desmoplastic stroma and immunosuppressive tumor microenvironment (TME), which facilitate tumor progression and metastasis. In addition, fibrous tissue leads to sparse vasculature, high inter...

Full description

Bibliographic Details
Main Authors: Maria Urbanova, Marina Cihova, Verona Buocikova, Jan Slopovsky, Peter Dubovan, Daniel Pindak, Miroslav Tomas, Laura García-Bermejo, Mercedes Rodríguez-Garrote, Julie Earl, Yvonne Kohl, Agapi Kataki, Maria Dusinska, Bruno Sainz, Jr., Bozena Smolkova, Alena Gabelova
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Pancreatic ductal adenocarcinoma
Tumor microenvironment
Epigenetics
Nanomedicine immunosuppression
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223009708

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223009708

Similar Items